At Ford Field on Thursday, Amon-Ra St. Brown and the Detroit Lions (7-5) face Javonte Williams and the Dallas Cowboys (6-5-1) in a matchup featuring two of the brightest stars in the NFL, beginning at ...

A first look at the upcoming Skoda Superb and Octavia, showcasing their new design direction, interior technology, platform updates, and features that will shape future Skoda models. This video ...

If your WiFi drops when you move rooms or connect too many devices, it is likely high time to upgrade to a mesh WiFi. Unlike traditional routers, a mesh WiFi system spreads multiple access points ...

A US Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean during UNITAS 2025 on Sept. 23, 2025. US Navy photo ARLINGTON, Va. — A new office consolidating the development ...

Process 'moving towards conclusion' minister says UN says 36 of its employees have been arrested UN rejects accusation its staff involved Hundreds of UN personnel remain in Houthi-controlled Yemen ...

Two 137 m replenishment ships for the Portuguese Navy, ordered from STM, shown in a concept graphic released in September 2025. (STM) Kongsberg Maritime has signed a contract with Turkish shipbuilder ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

In six years, Phillips helped turn Ras Al Khaimah from a little-known tourism destination to a booming development spot, home to the country’s first legal casino. Raki Phillips is stepping down as CEO ...

Revolution Medicines, Inc. and Summit Therapeutics, Inc. have announced a clinical collaboration to evaluate the safety and efficacy of Revolution Medicines' RAS(ON) inhibitors, including daraxonrasib ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.